Terms: = Brain cancer AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721 AND Treatment
250 results:
1. Gelsolin knockdown confers radiosensitivity to glioblastoma cells.
Gao D; Jiang T; Liu Y
Cancer Med; 2024 May; 13(10):e7286. PubMed ID: 38803199
[TBL] [Abstract] [Full Text] [Related]
2. Demethylation of TIMP2 and TIMP3 Inhibits Cell Proliferation, Migration, and Invasion in Pituitary Adenomas.
Yang Y; Huang F; Wu X; Huang C; Li Y
Discov Med; 2024 May; 36(184):971-980. PubMed ID: 38798256
[TBL] [Abstract] [Full Text] [Related]
3. Autophagy-related CMTM6 promotes glioblastoma progression by activating Wnt/β-catenin pathway and acts as an onco-immunological biomarker.
Dai L; Xiao J; Li X; Tao Y; Zhou P; Lyu L; Shi Z; Liang X; Jia Z; Jiang S
J Gene Med; 2024 May; 26(5):e3685. PubMed ID: 38686653
[TBL] [Abstract] [Full Text] [Related]
4. PUMC-MB1 is a novel group 3 medulloblastoma preclinical model, sensitive to PI3K/mTOR dual inhibitor.
Wang S; Zhang D; Wang J; Peng X; Sun H; Ji Y; Yang Z; Bian X; Hou Y; Ge M; Liu Y
J Neurooncol; 2024 May; 168(1):139-149. PubMed ID: 38662151
[TBL] [Abstract] [Full Text] [Related]
5. Recent advances in tyrosine kinase inhibitors VEGFR 1-3 for the treatment of advanced metastatic melanoma.
Sobczuk P; Cholewiński M; Rutkowski P
Expert Opin Pharmacother; 2024 Apr; 25(5):501-510. PubMed ID: 38607407
[TBL] [Abstract] [Full Text] [Related]
6. Regorafenib and glioblastoma: a literature review of preclinical studies, molecular mechanisms and clinical effectiveness.
Mongiardi MP; Pallini R; D'Alessandris QG; Levi A; Falchetti ML
Expert Rev Mol Med; 2024 Apr; 26():e5. PubMed ID: 38563164
[TBL] [Abstract] [Full Text] [Related]
7. Comprehensive genomic profiling to identify actionable alterations for breast cancer brain metastases in the Chinese population.
Lu Q; Wang N; Jiang K; Zhou H; Zhang P; Zhang J; Wang S; Sun P; Xu F
ESMO Open; 2024 Mar; 9(3):102389. PubMed ID: 38460250
[TBL] [Abstract] [Full Text] [Related]
8. Genistin Represses the Proliferation and Angiogenesis While Accelerating the Apoptosis of Glioma Cells by Modulating the FOXC1-Mediated Wnt Signaling Pathway.
Lan X; Gui Z; Chen T; Tang M; Wang H
Discov Med; 2024 Feb; 36(181):332-342. PubMed ID: 38409838
[TBL] [Abstract] [Full Text] [Related]
9. Etomidate inhibits tumor growth of glioblastoma by regulating M1 macrophage polarization.
Gao C; Nie Y
Metab Brain Dis; 2024 Apr; 39(4):569-576. PubMed ID: 38300392
[TBL] [Abstract] [Full Text] [Related]
10. Avapritinib-based SAR studies unveil a binding pocket in kit and PDGFRA.
Teuber A; Schulz T; Fletcher BS; Gontla R; Mühlenberg T; Zischinsky ML; Niggenaber J; Weisner J; Kleinbölting SB; Lategahn J; Sievers S; Müller MP; Bauer S; Rauh D
Nat Commun; 2024 Jan; 15(1):63. PubMed ID: 38167404
[TBL] [Abstract] [Full Text] [Related]
11. Anlotinib alone or in combination with bevacizumab in the treatment of recurrent high-grade glioma: a prospective single-arm, open-label phase II trial.
Zhao S; Zhang M; Zhang Q; Wu J; Dai H
BMC Cancer; 2024 Jan; 24(1):6. PubMed ID: 38166698
[TBL] [Abstract] [Full Text] [Related]
12. Metformin inhibits cell proliferation and ACTH secretion in AtT20 cells via regulating the MAPK pathway.
Sun Y; Cheng J; Nie D; Fang Q; Li C; Zhang Y
Mol Cell Endocrinol; 2024 Mar; 582():112140. PubMed ID: 38147953
[TBL] [Abstract] [Full Text] [Related]
13. Circ_0005015 upregulates BACH1 to promote aggressive behaviors in glioblastoma by sponging microRNA-382-5p.
Shao Y; Yang Z; Miao W; Yu X; Pu Y
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):4139-4151. PubMed ID: 38032493
[TBL] [Abstract] [Full Text] [Related]
14. NRF1 Alleviated Oxidative Stress of Glioblastoma Cells by Regulating NOR1.
Wang J; Chen S; Xiang W; Zhu Q; Ren N
Folia Biol (Praha); 2023; 69(1):13-21. PubMed ID: 37962027
[TBL] [Abstract] [Full Text] [Related]
15. General features, pathogenesis, and laboratory diagnostics of autoimmune encephalitis.
Masciocchi S; Businaro P; Scaranzin S; Morandi C; Franciotta D; Gastaldi M
Crit Rev Clin Lab Sci; 2024 Jan; 61(1):45-69. PubMed ID: 37777038
[TBL] [Abstract] [Full Text] [Related]
16. Adipose‑derived stem cell‑mediated alphastatin targeting delivery system inhibits angiogenesis and tumor growth in glioma.
Liang C; Wei T; Zhang T; Niu C
Mol Med Rep; 2023 Nov; 28(5):. PubMed ID: 37772382
[TBL] [Abstract] [Full Text] [Related]
17. Ar-turmerone inhibits the proliferation and mobility of glioma by downregulating cathepsin B.
Cao W; Chen X; Xiao C; Lin D; Li Y; Luo S; Zeng Z; Sun B; Lei S
Aging (Albany NY); 2023 Sep; 15(18):9377-9390. PubMed ID: 37768200
[TBL] [Abstract] [Full Text] [Related]
18. EZH2-regulated PARP-1 Expression is a Likely Mechanism for the Chemoresistance of Gliomas to Temozolomide.
Liang Q; Wang B; Zhang C; Song C; Wang J; Sun W; Jiang L; Lin J
Curr Cancer Drug Targets; 2024; 24(3):328-339. PubMed ID: 37594167
[TBL] [Abstract] [Full Text] [Related]
19. The RNA polymerase II subunit B (RPB2) functions as a growth regulator in human glioblastoma.
Li XL; Xie Y; Chen YL; Zhang ZM; Tao YF; Li G; Wu D; Wang HR; Zhuo R; Pan JJ; Yu JJ; Jia SQ; Zhang Z; Feng CX; Wang JW; Fang F; Qian GH; Lu J; Hu SY; Li ZH; Pan J
Biochem Biophys Res Commun; 2023 Sep; 674():170-182. PubMed ID: 37423037
[TBL] [Abstract] [Full Text] [Related]
20. Inhibition of extranodal NK/T-cell lymphoma by Chiauranib through an AIF-dependent pathway and its synergy with L-asparaginase.
Gao T; Huang J; Yin H; Huang J; Xie J; Zhou T; Fan W; Yang X; Gao G; Li Z
Cell Death Dis; 2023 May; 14(5):316. PubMed ID: 37160920
[TBL] [Abstract] [Full Text] [Related]
[Next]
